TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,673 | -99.1% | 70,870 | +1537.5% | 0.00% | – |
| Q2 2021 | $311,000 | -76.0% | 4,328 | -81.7% | 0.00% | -100.0% |
| Q3 2020 | $1,295,000 | -51.5% | 23,607 | -41.3% | 0.00% | -60.0% |
| Q2 2020 | $2,672,000 | +990.6% | 40,190 | +904.8% | 0.01% | +400.0% |
| Q1 2020 | $245,000 | -94.9% | 4,000 | -92.7% | 0.00% | -90.9% |
| Q4 2019 | $4,793,000 | -53.9% | 54,506 | -60.5% | 0.01% | -54.2% |
| Q3 2019 | $10,404,000 | -19.8% | 137,899 | -9.2% | 0.02% | -17.2% |
| Q2 2019 | $12,974,000 | -28.1% | 151,879 | -9.0% | 0.03% | -32.6% |
| Q1 2019 | $18,045,000 | +11.5% | 166,942 | -12.7% | 0.04% | +2.4% |
| Q4 2018 | $16,184,000 | -20.3% | 191,208 | -7.4% | 0.04% | -8.7% |
| Q3 2018 | $20,304,000 | -16.9% | 206,547 | -2.2% | 0.05% | -23.3% |
| Q2 2018 | $24,439,000 | +848.7% | 211,247 | +709.7% | 0.06% | +900.0% |
| Q1 2018 | $2,576,000 | -76.8% | 26,091 | -75.4% | 0.01% | -77.8% |
| Q4 2017 | $11,093,000 | – | 105,941 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |